A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02714608 · UNKNOWN
Trial details
- NCT number
- NCT02714608
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-05-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.